Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $64.5000 (-6.28%) ($62.5500 - $67.7500) on Mon. Mar. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3% (three month average) | RSI | 28 | Latest Price | $64.5000(-6.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -2.7% a day on average for past five trading days. | Weekly Trend | ABBV declines -11.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) SPLV(48%) DIA(47%) VYM(47%) IVE(45%) | Factors Impacting ABBV price | ABBV will decline at least -1.5% in a week (0% probabilities). VIXM(-32%) VXX(-11%) TLT(-11%) UUP(-5%) IGOV(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.5% (StdDev 3%) | Hourly BBV | -1.5 () | Intraday Trend | -3.8% | | | |
|
1 - 5 Day Possible Target | $54.48(-15.53%) | Resistance Level | $81.57 | 5 Day Moving Average | $69.69(-7.45%) | 10 Day Moving Average | $75.46(-14.52%) | 20 Day Moving Average | $81.57(-20.93%) | To recent high | -34% | To recent low | 0% | Market Cap | $113.796b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |